{"id":"https://openalex.org/W2525797360","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9004","title":"Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study.","display_name":"Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2525797360","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9004","mag":"2525797360"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.9004","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9004","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9004","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055965589","display_name":"Daniel Richard Gomez","orcid":"https://orcid.org/0009-0003-8617-3868","observed_orcids":["https://orcid.org/0009-0003-8617-3868"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Richard Gomez","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077579849","display_name":"George R. Blumenschein","orcid":"https://orcid.org/0000-0002-9606-8194","observed_orcids":["https://orcid.org/0000-0002-9606-8194"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George R. Blumenschein","raw_affiliation_strings":["Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Jack Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Jack Lee","raw_affiliation_strings":["Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085977067","display_name":"Mike Hern\u00e1ndez","orcid":"https://orcid.org/0000-0002-5074-5460","observed_orcids":["https://orcid.org/0000-0002-5074-5460"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mike Hernandez","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082517668","display_name":"D. Ross Camidge","orcid":"https://orcid.org/0000-0003-3430-3213","observed_orcids":["https://orcid.org/0000-0003-3430-3213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Ross Camidge","raw_affiliation_strings":["University of Colorado, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Aurora, CO;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034705456","display_name":"Robert Charles Doebele","orcid":"https://orcid.org/0000-0001-6728-6857","observed_orcids":["https://orcid.org/0000-0001-6728-6857"]},"institutions":[{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Charles Doebele","raw_affiliation_strings":["University of Colorado Anschutz Medical Campus, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Anschutz Medical Campus, Aurora, CO;","institution_ids":["https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109156278","display_name":"Laurie E. Gaspar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laurie E. Gaspar","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO;","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010884206","display_name":"Don Lynn Gibbons","orcid":"https://orcid.org/0000-0003-2362-3094","observed_orcids":["https://orcid.org/0000-0003-2362-3094"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Don Lynn Gibbons","raw_affiliation_strings":["Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073556374","display_name":"Jose Antonio Karam","orcid":"https://orcid.org/0000-0001-7697-9591","observed_orcids":["https://orcid.org/0000-0001-7697-9591"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jose A. Karam","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052966036","display_name":"Brian D. Kavanagh","orcid":"https://orcid.org/0000-0001-5579-1725","observed_orcids":["https://orcid.org/0000-0001-5579-1725"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian D. Kavanagh","raw_affiliation_strings":["University of Colorado Denver, Aurora, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Denver, Aurora, CO;","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060222943","display_name":"Ritsuko U Komaki","orcid":"https://orcid.org/0000-0003-0084-6017","observed_orcids":["https://orcid.org/0000-0003-0084-6017"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ritsuko Komaki","raw_affiliation_strings":["Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038486476","display_name":"Alexander V. Louie","orcid":"https://orcid.org/0000-0002-3569-9099","observed_orcids":["https://orcid.org/0000-0002-3569-9099"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander V. Louie","raw_affiliation_strings":["Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090288280","display_name":"David A. Palma","orcid":"https://orcid.org/0000-0002-9542-0627","observed_orcids":["https://orcid.org/0000-0002-9542-0627"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Palma","raw_affiliation_strings":["Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, London Regional Cancer Program, London, ON, Canada;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057281549","display_name":"Anne S. Tsao","orcid":"https://orcid.org/0000-0003-0505-6639","observed_orcids":["https://orcid.org/0000-0003-0505-6639"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne S. Tsao","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048478992","display_name":"William Nassib William","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Nassib William","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100358178","display_name":"Jianjun J. Zhang","orcid":"https://orcid.org/0000-0001-7872-3477","observed_orcids":["https://orcid.org/0000-0001-7872-3477"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianjun Zhang","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076621000","display_name":"Stephen G. Swisher","orcid":"https://orcid.org/0000-0002-3080-1920","observed_orcids":["https://orcid.org/0000-0002-3080-1920"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Swisher","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048380048","display_name":"John Victor Heymach","orcid":"https://orcid.org/0000-0001-9068-8942","observed_orcids":["https://orcid.org/0000-0001-9068-8942"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Heymach","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"9004","last_page":"9004"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.8593999743461609,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.8593999743461609,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.13660000264644623,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/local-consolidative-therapy","display_name":"local consolidative therapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/oligometastatic-non-small-cell-lung-cancer","display_name":"oligometastatic non-small cell lung cancer","score":0.972000002861023},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9470000267028809},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/surgical-resection-of-metastases","display_name":"surgical resection of metastases","score":0.8640000224113464},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.7519999742507935},{"id":"https://openalex.org/keywords/alk-fusion","display_name":"ALK fusion","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metastasis-directed-therapy","display_name":"metastasis-directed therapy","score":0.527999997138977},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.5590000152587891},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.843999981880188},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":1.0},{"id":"https://openalex.org/keywords/stage-iv-lung-cancer","display_name":"stage IV lung cancer","score":0.6159999966621399},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9229609966278076},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6816692352294922},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.6507158875465393},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5470297932624817},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.5369752049446106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5330266952514648},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5294482707977295},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.510511040687561},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4858255386352539},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.4676463305950165},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4672790765762329},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.45792919397354126},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.4425925016403198},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.394202321767807},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.368802547454834},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2709381580352783},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.11537599563598633},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.9004","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.9004","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.9004","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7099999785423279,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2944301866","https://openalex.org/W2901517592","https://openalex.org/W4239779587","https://openalex.org/W2946546618","https://openalex.org/W2990557327","https://openalex.org/W2536769127","https://openalex.org/W4213197346","https://openalex.org/W4205935413","https://openalex.org/W2954722070","https://openalex.org/W4400037510"],"abstract_inverted_index":{"9004":[0],"Background:":[1],"We":[2],"performed":[3,29],"a":[4,205,288,293,299],"randomized":[5,87,148,191],"study":[6,27,144,174,186],"to":[7,88,133,179,228,255,316,342],"assess":[8],"the":[9,121,170,173,185,212,217,236,248,264,268,283],"effect":[10],"of":[11,68,76,95,156,199,209,301],"aggressive":[12],"LCT":[13,90,125,196,218,265,336],"in":[14,184,195,216,235,247,263,274,277,282,287,292,298],"patients":[15,79,189,246,270,314,326],"with":[16,80,120],"oligometastatic":[17,324],"NSCLC":[18,325],"who":[19],"did":[20],"not":[21,309],"progress":[22],"after":[23,57,333],"IST.":[24,58],"Methods:":[25],"This":[26],"was":[28,61,108,118,146,151,175,220,261],"at":[30],"MD":[31],"Anderson,":[32],"U.":[33],"Colorado,":[34],"and":[35,52,164,296,313],"London":[36],"HSC,":[37],"Canada.":[38],"Eligibility:":[39],"1)":[40],"histologically":[41],"confirmed":[42],"NSCLC,":[43],"2)":[44],"Stage":[45],"IV":[46],"disease,":[47],"3)":[48],"\u2264":[49,328],"3":[50,74,286,329],"metastases,":[51,157,161],"4)":[53],"no":[54],"RECIST":[55],"progression":[56,281,332],"Appropriate":[59],"IST":[60,158],"defined":[62],"as":[63],"either":[64,89],"\u2265":[65,73],"4":[66,131],"cycles":[67],"platinum":[69],"doublet":[70],"therapy":[71,100],"or":[72,92],"months":[75,132,135,222,230],"erlotinib/crizotinib":[77],"for":[78,319],"EGFR":[81],"mutations/ALK":[82],"fusions,":[83],"respectively.":[84],"Patients":[85],"were":[86,190],"([chemo]radiation":[91],"surgical":[93],"resection":[94],"all":[96],"sites)":[97],"+/-":[98,337],"systemic":[99],"(ST)":[101],"vs.":[102],"ST":[103,106,338,343],"alone.":[104,344],"The":[105,115,142,303],"regimen":[107],"physician":[109],"choice":[110],"from":[111,130,192],"predefined":[112],"standard-of-care":[113],"regimens.":[114],"primary":[116,284],"endpoint":[117],"PFS,":[119],"hypothesis":[122],"that":[123,271],"immediate":[124,335],"would":[126],"improve":[127],"PFS":[128,214,340],"time":[129,208,215,307],"7":[134,198,279,291],"(HR":[136,239],"=":[137,240,243],"0.57)":[138],"using":[139],"ITT":[140],"analysis.":[141],"planned":[143],"size":[145],"94":[147],"patients.":[149],"Randomization":[150],"balanced":[152],"dynamically":[153],"by":[154],"number":[155],"response,":[159],"CNS":[160],"nodal":[162],"status,":[163],"EGFR/ALK":[165,202],"status.":[166],"Results:":[167],"Based":[168],"on":[169],"DSMC":[171],"recommendation,":[172],"closed":[176],"early":[177],"due":[178,254],"significant":[180],"efficacy":[181],"benefit":[182],"observed":[183,262],"arm.":[187],"49":[188],"2/2013-1/2016":[193],"(25":[194],"arm),":[197],"which":[200],"had":[201,280],"alterations.":[203],"At":[204],"median":[206,213,304],"follow-up":[207],"16.2":[210],"months,":[211],"arm":[219,238,250],"14.4":[221],"(95%":[223,231],"CI":[224,232],"5.2":[225],"months-NR),":[226],"compared":[227,341],"3.9":[229],"2.2-6.6":[233],"months)":[234],"no-LCT":[237,249],"0.36,":[241],"p":[242],"0.013).":[244],"Seventeen":[245],"crossed":[251],"over,":[252],"14":[253],"progression.":[256],"No":[257],"grade":[258],"3-5":[259],"toxicity":[260],"group.":[266],"Of":[267],"28":[269],"progressed":[272],"(12":[273],"LCT,":[275],"16":[276],"no-LCT),":[278],"site,":[285],"known":[289],"metastasis,":[290,295],"different":[294],"11":[297],"combination":[300],"sites.":[302],"overall":[305],"survival":[306],"has":[308],"yet":[310],"been":[311],"reached":[312],"continue":[315],"be":[317],"followed":[318],"this":[320],"endpoint.":[321],"Conclusions:":[322],"In":[323],"(":[327],"mets)":[330],"without":[331],"IST,":[334],"improved":[339],"Clinical":[345],"trial":[346],"information:":[347],"NCT01725165.":[348]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-10-07T00:00:00"}